Cyclacel Pharmaceuticals, Inc

CYCC

...

CYCC: Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

Show CYCC Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of CYCC by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by CYCC's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on CYCC's company Twitter account

WallStreetBets

Number of mentions of CYCC in WallStreetBets Daily Discussion

CYCC News

Recent insights relating to CYCC

CNBC Recommendations

Recent picks made for CYCC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CYCC

Corporate Flights

Flights by private jets registered to CYCC